Predictions
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.54
15.10.22
15.10.22
€2.00
15.10.23
15.10.23
-0.88%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€8.22
15.10.22
15.10.22
€0.000
15.10.23
15.10.23
2.13%
29.10.22
29.10.22
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Banca Monte dei Paschi di Siena SpA
Start price
Target price
Perf. (%)
€2.05
15.10.22
15.10.22
€4.00
15.10.23
15.10.23
-4.85%
29.10.22
29.10.22
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected
Business model of the past or high risk
Db X-trackers FTSE 100 Short Daily Ucits Etf
Start price
Target price
Perf. (%)
€3.70
15.10.22
15.10.22
-
15.10.23
15.10.23
-7.06%
11.11.22
11.11.22
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.63
14.10.22
14.10.22
€5.00
14.10.23
14.10.23
-84.59%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Moderna Inc.
Start price
Target price
Perf. (%)
€137.82
13.10.22
13.10.22
-
13.10.23
13.10.23
5.79%
23.02.23
23.02.23
Significant cyclical dependencies
Higher risks for its business
B.R.A.I.N. Biotechnology Research and Information Network AG
Start price
Target price
Perf. (%)
€4.98
13.10.22
13.10.22
-
13.10.23
13.10.23
-18.27%
14.10.23
14.10.23
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Applied Materials Inc.
Start price
Target price
Perf. (%)
€80.66
13.10.22
13.10.22
€140.00
13.10.23
13.10.23
66.23%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Novavax Inc.
Start price
Target price
Perf. (%)
€21.36
13.10.22
13.10.22
€20.00
13.10.23
13.10.23
-48.44%
11.01.23
11.01.23
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Columbia Care Inc.
Start price
Target price
Perf. (%)
€1.59
13.10.22
13.10.22
€1.90
13.10.23
13.10.23
-54.52%
11.01.23
11.01.23
Capable Management
Innovative
Bad rating
Few uniques
Carbios S.A.
Start price
Target price
Perf. (%)
€23.36
13.10.22
13.10.22
€30.60
20.09.23
20.09.23
0.17%
21.09.23
21.09.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Siemens Energy AG
Start price
Target price
Perf. (%)
€10.70
13.10.22
13.10.22
€15.00
13.10.23
13.10.23
-3.23%
13.10.22
13.10.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€67.38
13.10.22
13.10.22
€46.00
13.10.23
13.10.23
9.44%
14.10.23
14.10.23
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Hyundai Motor Co ADR
Start price
Target price
Perf. (%)
€28.40
13.10.22
13.10.22
€40.00
13.10.23
13.10.23
27.11%
14.10.23
14.10.23
Could be very worthwhile Investment >20% year
Fair valuation
Normal challenges to pay loans and raise capital
Good rating